A detailed history of Quest Partners LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 13,593 shares of TXG stock, worth $207,972. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,593
Previous 17,014 20.11%
Holding current value
$207,972
Previous $331 Million 7.25%
% of portfolio
0.03%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$15.71 - $23.49 $53,743 - $80,359
-3,421 Reduced 20.11%
13,593 $307 Million
Q2 2024

Aug 06, 2024

SELL
$19.45 - $37.37 $18,283 - $35,127
-940 Reduced 5.24%
17,014 $331 Million
Q1 2024

May 09, 2024

BUY
$36.08 - $54.3 $647,780 - $974,902
17,954 New
17,954 $674 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.45B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.